This inventor holds 1 USPTO granted patent. Top assignee: Societe Civile Bioprojet. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Jeanne-Marie Lecounte: Innovator in Medicinal Chemistry
Introduction
Jeanne-Marie Lecounte is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that interact with histamine H-receptors. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Jeanne-Marie Lecounte holds a patent for the use of a compound of formula (A). This compound is designed to impart antagonistic and/or agonistic activity at histamine H-receptors when attached to an imidazole ring in the 4(5) position. The patent details that R and R may be identical or different and can represent a variety of chemical structures, including lower alkyl or cycloalkyl groups. This invention is aimed at preparing medicaments that act as antagonists and/or agonists at the H-receptors of histamine, showcasing her innovative approach to drug development.
Career Highlights
Throughout her career, Jeanne-Marie has demonstrated a strong commitment to research and innovation. Her work at Societe Civile Bioprojet has allowed her to explore new avenues in medicinal chemistry. With a focus on developing effective treatments, she has positioned herself as a key player in her field.
Collaborations
Jeanne-Marie has collaborated with notable colleagues, including Jean-Charles Schwartz and Monique Garbarg. These partnerships have enriched her research and contributed to the advancement of her projects.
Conclusion
Jeanne-Marie Lecounte is a trailblazer in the field of medicinal chemistry, with a patent that highlights her innovative contributions to drug development. Her work continues to impact the medical community positively, and her collaborations further enhance her research endeavors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile